Fair Value Measurements and Fair Value of Instruments (Tables)

3 Months Ended

Mar. 31, 2025

Fair Value Disclosures [Abstract]

Summary of Carrying Values and Fair Values of Financial Instruments

The following tables display the carrying values and fair values of financial instruments.


				As of
				March 31, 2025												December 31, 2024
Assets on the Condensed Consolidated Balance Sheets				Carrying Value				Unrealized Losses				Fair Value				Carrying Value				Unrealized Losses				Fair Value
Cash and cash equivalents		Level 1		$	125,600			$	-			$	125,600			$	142,482			$	-			$	142,482
Total				$	125,600			$	-			$	125,600			$	142,482			$	-			$	142,482

The Company reports the current portion of restricted cash as a separate item in the Condensed Consolidated Balance Sheets and the non-current portion is a component of other long-term assets in the Condensed Consolidated Balance Sheets.


				As of
				March 31, 2025								December 31, 2024
Liabilities on the Condensed Consolidated Balance Sheets				Carrying Value				Fair Value				Carrying Value				Fair Value
Acquisition earnout payment		Level 3		$	1,760			$	1,760			$	1,760			$	1,760
Total liabilities				$	1,760			$	1,760			$	1,760			$	1,760

Schedule of Changes In Fair Value of Liabilities

The changes in the fair value of the Company's Level 3 liabilities for the three months ended March 31, 2025 and year ended December 31, 2024 are as follows.


				As of
				March 31, 2025				December 31, 2024
Balance at beginning of period				$	1,760			$	4,250
Payment of earnout in connection with the iQuue acquisition					-				(1,530	)
Change in fair value of earnout					-				(960	)
Balance at end of period				$	1,760			$	1,760

Schedule of Earnout of Measurement

The following table sets forth the weighted-average assumptions used to estimate the fair value of the earnout payment as of March 31, 2025 and December 31, 2024.


				As of
				March 31, 2025				December 31, 2024
Discount Rate					18.50	%			12.30	%
Volatility					40.00	%			40.00	%